“…In fact, obesity, predominantly abdominal, is recognized as an important determinant of metabolic risk in these patients (Azziz et al, 2004;Spritzer and Wiltgen, 2007). In PCOS, elevated leptin serum levels have been associated with amount of adipose tissue, waist circumference, insulin resistance, and hyperandrogenemia (Spritzer et al, 2001;Carmina et al, 1999Carmina et al, , 2005, while adiponectin levels have been reported to be decreased (Ardawi and Rouzi, 2005;EscobarMorreale, 2006;Jakubowska et al, 2008;Carmina et al, 2005Carmina et al, , 2009 or unchanged (Orio et al, 2003;Sprangler et al, 2004;Gulcelik et al, 2006). In this paper, we briefly review the emerging evidence linking adipose tissue expression of leptin and adiponectin and serum adipokine levels in women with PCOS.…”